The article examines whether the newly launched TrumpRX program can reduce federal employees’ out-of-pocket prescription drug costs. It focuses on healthcare affordability and what the program could mean for feds looking to lower pharmacy expenses.
Read full story at Federal News Network →Related Topics
prescription-drugsdrug-pricingout-of-pocket-costshealthcare-affordabilityfehb